Abstract
This Viewpoint discusses the ophthalmic device, red light therapy, for myopia treatment in children and adolescents in China, including its development and use, safety concerns, and implications surrounding recent regulatory changes and reclassification of this device.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have